Dr. D. B. Patil.PATIL PRADEEP BHATU2017-10-042017-10-042006http://krishikosh.egranth.ac.in/handle/1/5810032190In the human interventional endovascular therapy, late stent thrombosis and in-stent restenosis (ISR) have emerged, as a major safety concern with use of drug eluting stents. Late stent thrombosis is associated with high mortality and morbidity. To enhance thrombo-resistance and reduce the dependence on long term dual antiplatelet therapy, use of biodegradable polymer stent platform and heparin along with sirolimus is one approach. Hence a Heparin-Sirolimus (HS) eluting stent (HSES) using biodegradable platform in an evolved in vivo rabbit balloon injured iliac artery model for stent thrombosis was evaluated for effects of dual drug elution on peristrut fibrin deposition and re-endotheliazationenVeterinary SurgeryStudyThesis